Scholarlink

<p>Facial nerve paresis during pregnancy and puerperium is not rare. Peripheral facial nerve palsy is the most frequent unilateral cranial neurological disorder. Presentation, prognosis and approach in this group can be challenging. This article studies the possible causes, approach, available treatment options, effectiveness of corticosteroid treatment and their outcomes, along with foetal outcomes at birth. Total 6 patients were studied and followed in this study, 4 during pregnancy (2 in 3rd trimester, 2 during the end of 2nd trimester), 1 during labour and 1 in puerperium. House-Brackmann Grading for facial nerve palsy was used and observed to be between Grade 2 to Grade 4. All patients were subjected to single drug high dose corticosteroid therapy (Prednisolone 1&#xa0;mg/kg body weight). 100% recovery was observed at the end of 3 months in all cases. Based on this study, we emphasise on early diagnosis, detailed clinical and systemic examination, early corticosteroid use and regular and targeted follow up to monitor systemic effects of corticosteroids. Corticosteroids were observed to be safe and effective as a single drug regimen.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Gestational Facial Nerve Palsy: Case Series and Insights into Treatment Outcomes

  • 期刊论文

  • 发表日期：

    2026年1月21日

查看全文
  • Richa Garg,
  • Pankhuri Mittal,
  • Ruchika Agrawal,
  • Preeti Bala,
  • Preeti Priyadarshi

摘要

Facial nerve paresis during pregnancy and puerperium is not rare. Peripheral facial nerve palsy is the most frequent unilateral cranial neurological disorder. Presentation, prognosis and approach in this group can be challenging. This article studies the possible causes, approach, available treatment options, effectiveness of corticosteroid treatment and their outcomes, along with foetal outcomes at birth. Total 6 patients were studied and followed in this study, 4 during pregnancy (2 in 3rd trimester, 2 during the end of 2nd trimester), 1 during labour and 1 in puerperium. House-Brackmann Grading for facial nerve palsy was used and observed to be between Grade 2 to Grade 4. All patients were subjected to single drug high dose corticosteroid therapy (Prednisolone 1 mg/kg body weight). 100% recovery was observed at the end of 3 months in all cases. Based on this study, we emphasise on early diagnosis, detailed clinical and systemic examination, early corticosteroid use and regular and targeted follow up to monitor systemic effects of corticosteroids. Corticosteroids were observed to be safe and effective as a single drug regimen.